REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Lumamed Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Full name: Lumamed Sp. z o.o. Profile Updated: June 27, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Lumamed Sp. z o.o. is based in Poland, with the head office in Warsaw. The company operates in the Pharmacies and Drug Stores industry. The company was established on September 28, 2020. The company’s latest financial report indicates a net sales revenue increase of 7.71% in 2023. Its total assets grew by 18.8% over the same period.

Headquarters
Ul. Poezji 17 A
Warsaw; Mazowieckie; Postal Code: 05-077

Contact Details: Purchase the Lumamed Sp. z o.o. report to view the information.

Website: http://www.lumamed.pl

Basic Information
Outstanding Shares:
Purchase the Lumamed Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Lumamed Sp. z o.o. report to view the information.
Incorporation Date:
September 28, 2020
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
33.33%
Purchase this report to view the information.
33.33%
Purchase this report to view the information.
33.33%
Company Performance
Financial values in the chart are available after Lumamed Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
7.71%▲
Total operating revenue
7.94%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
18.8%▲
Total equity
15.1%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo